WebJun 4, 2012 · Recombinant human DNase I (Pulmozyme, dornase alfa) is used for the treatment of cystic fibrosis where it improves lung function and reduces the number of exacerbations. The physiological mechanism of action is thought to involve the reduction of the viscoelasticity of cystic fibrosis sputum by hydrolyzing high concentrations of DNA … WebBackground: Recombinant human deoxyribonuclease (rhDNase) is currently used to treat pulmonary disease (the major cause of morbidity and mortality) in cystic fibrosis. …
RhDNase - definition of rhDNase by The Free Dictionary
WebDornase alpha (rhDNase) is a recombinant human deoxyribonuclease. Aerosolized dornase was one of the earlier lung directed therapies proposed for CF [186]. Shak et al. were able to clone, sequence and express rhDNase I. They then exposed samples of CF sputum to rhDNase, which significantly reduced sputum viscosity compared to controls … WebNational Center for Biotechnology Information gba hippotherapie
The Structure of Human DNase I Bound to Magnesium and …
WebDec 14, 2011 · The aim of this study was to evaluate the antibiofilm activity of recombinant human DNase I (rhDNase) against Staphylococcus aureus and Staphylococcus epidermidis. Using a 96-well microtiter plate ... WebAug 15, 2012 · Once-daily nebulised recombinant human deoxyribonuclease (rhDNase; dornase alfa; Pulmozyme®) is the most widely used mucoactive therapy in patients with CF. It has been shown to reduce the viscoelasticity of sputum from patients with CF and enhance the clearance of secretions. Clinical trials have shown rhDNase to be a well … WebMar 19, 1992 · Recombinant human deoxyribonuclease I (rhDNase) offers the possibility of specifically cleaving DNA in purulent lung secretions and may thus help patients with cystic fibrosis to remove secretions ... gba kingdom hearts